S. Patrick Kachur

S. Patrick Kachur


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MDMeghna R. Desai
Meghna R. Desai
ASAaron M. Samuels
Aaron M. Samuels
WOWycliffe Odongo
Wycliffe Odongo
JWJohn Williamson
John Williamson
NONobert Awino Odero
Nobert Awino Odero
KLKim A. Lindblade
Kim A. Lindblade
Progress with malaria control in western Kenya has stagnated since 2007. Additional interventions to reduce the high burden of malaria in this region are urgently needed. We conducted a two-arm, community-based, cluster-randomized, controlled trial of active case detection and treatment of malaria infections in all residents mass testing and treatment (MTaT) of 10 village clusters (intervention clusters) for two consecutive years to measure differences in the incidence of clinical malaria disease and malaria infections compared with 20 control clusters where MTaT was not implemented. All residents of intervention clusters, irrespective of history of fever or other malaria-related symptoms, were tested three times per year before the peak malaria season using malaria rapid diagnostic tests. All positive cases were treated with dihydroartemisinin–piperaquine. The incidence of clinical malaria was measured through passive surveillance, whereas the cumulative incidence of malaria infection was measured using active surveillance in a cohort comprising randomly selected residents. The incidence of clinical malaria was 0.19 cases/person-year (p-y, 95% CI: 0.13–0.28) in the intervention arm and 0.24 cases/p-y (95% CI: 0.15–0.39) in the control arm (incidence rate ratio [IRR] 0.79, 95% CI: 0.61–1.02). The cumulative incidence of malaria infections was similar between the intervention (2.08 infections/p-y, 95% CI: 1.93–2.26) and control arms (2.19 infections/p-y, 95% CI: 2.02–2.37) with a crude IRR of 0.95 (95% CI: 0.87–1.04). Six rounds of MTaT over 2 years did not have a significant impact on the incidence of clinical malaria or the cumulative incidence of malaria infection in this area of high malaria transmission.

1 July 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
LZLaura Divens Zambrano
Laura Divens Zambrano
EJEmily Jentes
Emily Jentes
CPChristina (Chris) Phares
Christina (Chris) Phares
MWMichelle Weinberg
Michelle Weinberg
SKS. Patrick Kachur
S. Patrick Kachur
NMNina Marano
Nina Marano
Tropical splenomegaly is often associated with malaria and schistosomiasis. In 2014 and 2015, 145 Congolese refugees in western Uganda diagnosed with splenomegaly during predeparture medical examinations underwent enhanced screening for various etiologies. After anecdotal reports of unresolved splenomegaly and complications after U.S. arrival, patients were reassessed to describe long-term clinical progression after arrival in the United States. Post-arrival medical information was obtained through medical chart abstraction in collaboration with state health partners in nine participating states. We evaluated observed splenomegaly duration and associated clinical sequelae between 130 case patients from eastern Congo and 102 controls through adjusted hierarchical Poisson models, accounting for familial clustering. Of the 130 case patients, 95 (73.1 %) had detectable splenomegaly after arrival. Of the 85 patients with records beyond 6 months, 45 (52.9%) had persistent splenomegaly, with a median persistence of 14.7 months (range 6.0-27.9 months). Of the 112 patients with available results, 65 (58.0%) patients had evidence of malaria infection, and the mean splenomegaly duration did not differ by Plasmodium species. Refugees with splenomegaly on arrival were 43% more likely to have anemia (adjusted relative risk [aRR]: 1.43, 95% CI: 1.04-1.97). Those with persistent splenomegaly were 60% more likely (adjusted relative risk [aRR]: 1.60, 95% CI: 1.15-2.23) to have a hematologic abnormality, particularly thrombocytopenia (aRR: 5.53, 95% CI: 1.73-17.62), and elevated alkaline phosphatase (aRR: 1.57, 95% CI: 1.03-2.40). Many patients experienced persistent splenomegaly, contradicting literature describing resolution after treatment and removal from an endemic setting. Other possible etiologies should be investigated and effective treatment, beyond treatment for malaria and schistosomiasis, explored.

15 September 2020 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
UBUsaini Bala
Usaini Bala
OAOlufemi Ajumobi
Olufemi Ajumobi
AUAmina Umar
Amina Umar
AAAdefisoye Adewole
Adefisoye Adewole
NWNdadilnasiya Endie Waziri
Ndadilnasiya Endie Waziri
KAKwame Asamoa
Kwame Asamoa
Background: In 2013, the Nigeria Federal Ministry of Health established a Master Health Facility List (MHFL) as recommended by WHO. Since then, some health facilities (HFs) have ceased functioning and new facilities were established. We updated the MHFL and assessed service delivery parameters in the Malaria Frontline Project implementing areas in Kano and Zamfara States. Methods: We assessed all HFs in each of the 34 project local government areas (LGAs) between July and September 2017. Project staff administered a semi-structured questionnaire developed for this assessment to heads of HFs about the type of facility, category and number of staff working at the facility and to record geo-coordinates of facility. Results: In the Kano State project area, 726 HFs were identified and geo-located: 31 were new facilities, 608 (84%), 116 (16%) and two (0.3%) were Primary Health Care (PHC), secondary and tertiary facilities respectively. Using the national definition, there were 710 (98%) functional facilities and 644 (91%) of these reported to the national health information platform, District Health Information System, version 2 (DHIS2). The Zamfara project area had 739 HFs: eight were new, 715 (97%), 22 (3.0%) and two (0.2%) PHCs, secondary and tertiary facilities respectively. There were 695 (94%) functional facilities with 656 (94%) of these reporting to DHIS2. Using national criteria for primary health care designation, only 95 (9%) of all PHCs in the two States met the minimum human resource requirements. Conclusion: Most HFs were functional and reported to DHIS2. A comprehensive MHFL having all the important parameters that should be established and updated regularly by authorities to make it more useful for health services administration and management. Most functional facilities are understaffed.

8 January 2026 in Global Implementation Research and Applications
Verified
Journal Article
Open access
PDF file
SFSally E. Findley
Sally E. Findley
LDLancina Doumbia
Lancina Doumbia
HBHamidou Oumar Ba
Hamidou Oumar Ba
BMBonkana Maiga
Bonkana Maiga
RBRokiatou Koné Béréthé
Rokiatou Koné Béréthé
SDSeydou Doumbia
Seydou Doumbia
Community-based diabetes prevention and control programs are effective but limited in West Africa. We assess adoption and effectiveness of a contextually adapted Diabetes Prevention Program “Power to Prevent” (DPP-P2P) in Bamako, Mali. Guided by implementation science principles, we adapted the DPP-P2P to align with Malian culture, integrating dietary and exercise modifications. Local audiovisuals and photo guides were created for healthy food preparation and exercises. Six community health centers with high diabetes rates were randomly assigned to intervention or comparison, and 429 individuals (≥ 25 years old with diabetes, hypertension, or obesity) consented to participate (intervention = 282; control = 147). Diabetes peer educators facilitated 14 bi-weekly sessions over six months. We assessed Hemoglobin A1c (HbA1c) and blood pressure and surveyed 15 key healthy lifestyle behaviors pre-and post-intervention. Retention was 77.1%, and groups especially liked the role plays, African audio-visuals, peer educator success stories, and demonstrations. In the intervention group, individuals wanting to weigh less increased from 31.5 to 58.9% ( p < 0.001), exercise days rose from 3.5 to 5.6 ( p < 0.001), and the desire for a healthier diet rose by 0.64 points. Average HbA1c in the intervention group dropped from 6.5% to 5.4% ( p = 0.001). The intervention increased the odds of lowering blood glucose below 6.5% by 2.31 times ( p = 0.020) and blood pressure below the hypertension threshold by 2.67 times ( p = 0.060). The Malian-adapted DPP-P2P was well accepted by the community, increasing the adoption of healthy behaviors and reducing blood glucose and hypertension. This program could benefit Mali and Sahelian countries in tackling diabetes and hypertension. Trial Registration ClinicalTrials.gov #NCT05260879. Registered 6 December 2021—Retrospectively registered (registration link: https://clinicaltrials.gov/study/NCT05260879).